Pages that link to "Item:Q2509459"
Jump to navigation
Jump to search
The following pages link to (Q2509459):
Displayed 9 items.
- Development of a bispecific antibody fragment for simultaneous cancer control and recruitment of immune system cells (BIKE) (Q77786) (← links)
- Innovative modular service platform PureApta for selecting modified pharmacies with diagnostic and therapeutic applications (Q78034) (← links)
- Service technology platform for searching for antibody fragments with therapeutic and diagnostic potential (Q78283) (← links)
- Development of a bispecific antineoplastic antibody (Q78486) (← links)
- Development of a first in the therapeutic class of a medical device for the treatment of myasthenic crisis in patients suffering from myastheniastheniaster disease (Q78631) (← links)
- Development of a first in the therapeutic class of a medical device for use in autoimmune neurodegenerative disease (Q78720) (← links)
- Development of therapy based on immunoligands recruiting the immune system to fight cancer. (Q80007) (← links)
- “Increasing the level of competitiveness and innovation of PURE Biologics Sp. z o.o. by gaining access to the capital market” (Q81995) (← links)
- Promotion of product brands of PURE Biologics on foreign markets through participation in the biotechnology and pharmaceuticals industry program (Q2688026) (← links)